• In late June 2026, Insperity, Inc. (NYSE:NSP) was removed from both the Russell 2000 Defensive Index and the Russell 2000 Growth-Defensive Index, prompting passive index funds to adjust their holdings.
• This dual index removal highlights how Insperity’s profile within quantitative and factor-based portfolios is changing just weeks before its scheduled July 29, 2026 second-quarter earnings release and analyst update.
• We’ll now examine how Insperity’s removal from key Russell defensive indices may influence its existing investment narrative and risk profile.

Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

Insperity Investment Narrative Recap

To own Insperity today, you need to believe that demand for outsourced HR among small and mid-sized businesses and the HRScale rollout can eventually translate into healthier margins, despite recent unexciting profitability and guidance that brackets possible Q2 losses. The dual Russell defensive index removals may add some short term trading volatility and tweak how quant and factor funds view the stock, but they do not fundamentally change the biggest near term risk around healthcare cost trends and margin pressure.

The most relevant recent announcement is Insperity’s Q2 and full year 2026 guidance, which frames expectations ahead of the July 29 earnings call that follows the index removals. With Q2 net income guided in a wide range of US$-10 million to US$9 million, and full year net income of US$18 million to US$56 million, investors are already focused on whether cost controls and pricing actions are enough to offset benefits inflation and support the investment case around HRScale.

Yet beneath the surface of HRScale’s promise, investors should be aware that concentrated reliance on a single benefits carrier and stubborn medical cost inflation could...

Insperity’s narrative projects $8.0 billion revenue and $94.5 million earnings by 2029.

Uncover how Insperity's forecasts yield a $40.50 fair value, a 11% downside to its current price.

Exploring Other Perspectives

Some of the lowest analysts were already cautious, assuming only about US$8.2 billion of revenue and US$95.6 million of earnings by 2028, which is a far more conservative path than the baseline story and could look either too harsh or too generous once the index removal and upcoming results reshape expectations.

Explore 4 other fair value estimates on Insperity - why the stock might be worth 25% less than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Insperity research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Insperity research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Insperity's overall financial health at a glance.

Curious About Other Options?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The latest GPUs need a type of rare earth metal called Terbium and there are only 30 companies in the world exploring or producing it. Find the list for free.
• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.